Cargando…

Correction: Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals

Detalles Bibliográficos
Autores principales: Kannan, N, Shanmuga Sundar, S, Balaji, S, Amuthan, Arul, Anil Kumar, NV, Balasubramanian, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019752/
https://www.ncbi.nlm.nih.gov/pubmed/29944723
http://dx.doi.org/10.1371/journal.pone.0200035
_version_ 1783335177427091456
author Kannan, N
Shanmuga Sundar, S
Balaji, S
Amuthan, Arul
Anil Kumar, NV
Balasubramanian, N
author_facet Kannan, N
Shanmuga Sundar, S
Balaji, S
Amuthan, Arul
Anil Kumar, NV
Balasubramanian, N
author_sort Kannan, N
collection PubMed
description
format Online
Article
Text
id pubmed-6019752
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-60197522018-07-07 Correction: Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals Kannan, N Shanmuga Sundar, S Balaji, S Amuthan, Arul Anil Kumar, NV Balasubramanian, N PLoS One Correction Public Library of Science 2018-06-26 /pmc/articles/PMC6019752/ /pubmed/29944723 http://dx.doi.org/10.1371/journal.pone.0200035 Text en © 2018 Kannan et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Kannan, N
Shanmuga Sundar, S
Balaji, S
Amuthan, Arul
Anil Kumar, NV
Balasubramanian, N
Correction: Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals
title Correction: Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals
title_full Correction: Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals
title_fullStr Correction: Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals
title_full_unstemmed Correction: Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals
title_short Correction: Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals
title_sort correction: physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019752/
https://www.ncbi.nlm.nih.gov/pubmed/29944723
http://dx.doi.org/10.1371/journal.pone.0200035
work_keys_str_mv AT kannann correctionphysiochemicalcharacterizationandcytotoxicityevaluationofmercurybasedformulationforthedevelopmentofanticancertherapeuticals
AT shanmugasundars correctionphysiochemicalcharacterizationandcytotoxicityevaluationofmercurybasedformulationforthedevelopmentofanticancertherapeuticals
AT balajis correctionphysiochemicalcharacterizationandcytotoxicityevaluationofmercurybasedformulationforthedevelopmentofanticancertherapeuticals
AT amuthanarul correctionphysiochemicalcharacterizationandcytotoxicityevaluationofmercurybasedformulationforthedevelopmentofanticancertherapeuticals
AT anilkumarnv correctionphysiochemicalcharacterizationandcytotoxicityevaluationofmercurybasedformulationforthedevelopmentofanticancertherapeuticals
AT balasubramaniann correctionphysiochemicalcharacterizationandcytotoxicityevaluationofmercurybasedformulationforthedevelopmentofanticancertherapeuticals